Abstract
Object
The SARC-F questionnaire is a sarcopenia screening tool. However, the validity of the SARC-F score ≥4 (SARC-F≥4) for the evaluation of sarcopenia in the hospital setting has not been investigated. This study investigated the validity of SARC-F≥4 as a screening tool for sarcopenia among hospitalized older adults.
Design
Cross-sectional retrospective study.
Setting
A university hospital.
Participants
This study included older adult patients (age ≥65 years) who were hospitalized at, and subsequently discharged from, the hospital between April and September 2019 and underwent a nutritional assessment by the nutrition support team during their hospitalization.
Measurements
SARC-F was recorded at the time of admission, and the criteria specified by the Asia Working Group for Sarcopenia in 2019 (AWGS 2019) were applied to diagnose sarcopenia and possible sarcopenia. Appendicular muscle mass was estimated through validated equations, and three different models were developed for sarcopenia diagnosis. The sensitivity, specificity, and positive/negative likelihood ratios were calculated to analyze the accuracy of the SARC-F≥4 for sarcopenia and possible sarcopenia. Receiver-operating characteristic analyses were conducted to calculate the area under the curve (AUC).
Results
In total, 1,689 patients (mean age: 77.2±13 years; male: 54.4%) were analyzed, and 636 patients (37.7%) had SARC-F≥4. Patients with SARC-F≥4 had a statistically significant higher prevalence of AWGS 2019-defined sarcopenia than patients with SARC-F <4 in the models (65.4–78.9% vs 40.9–15.2%, p<0.001). The sensitivity, specificity, and positive/negative likelihood ratios of SARC-F≥4 for sarcopenia and possible sarcopenia were 49.1–51.3%, 73.9–81.2%, and 1.88–2.72/0.60–0.69 and 48.0%, 84.5%, and 3.11/0.62, respectively. The AUC for sarcopenia and possible sarcopenia were 0.644–0.695 and 0.708, respectively. The AUC of SARC-F for possible sarcopenia was equivalent to or larger than that for sarcopenia (DeLong test p=0.438, 0.088, and <0.001 vs the three models).
Conclusions
SARC-F≥4 is suitable as a screening tool for sarcopenia in hospitalized older adults. SARC-F assessment could facilitate the detection and exclusion of sarcopenia at hospitalization and may lead to early adoption of a therapeutic and preventive approach.
Similar content being viewed by others
References
Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16–31.
Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39(4):412–23.
Maeda K, Akagi J. Sarcopenia is an independent risk factor of dysphagia in hospitalized older people. Geriatr Gerontol Int. 2016;16(4):515–21.
Chen LK, Liu LK, Woo J, et al. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc. 2014;15(2):95–101.
Studenski SA, Peters KW, Alley DE, et al. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sei Med Sei. 2014;69(5):547–S8.
Morley JE. Frailty and sarcopenia in elderly. Wien Klin Wochenschr. 2016;128(Suppl 7):439–45.
Chen LK, Woo J, Assantachai P, et al. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. J Am Med Dir Assoc. 2020;21(3):300–7e2.
Papadopoulou SK, Tsintavis P, Potsaki P, Papandreou D. Differences in the Prevalence of Sarcopenia in Community-Dwelling, Nursing Home and Hospitalized Individuals. A Systematic Review and Meta-Analysis. J Nutr Health Aging. 2020;24(1):83–90.
Ishida Y, Maeda K, Nonogaki T, et al. Impact of edema on length of calf circumference in older adults. Geriatr Gerontol Int. 2019; 19(10):993–8.
Malmstrom TK, Morley JE. SARC-F: a simple questionnaire to rapidly diagnose sarcopenia. J Am Med Dir Assoc. 2013;14(8):S31–2.
Kim S, Kim M, Won CW. Validation of the Korean Version of the SARC-F Questionnaire to Assess Sarcopenia: Korean Frailty and Aging Cohort Study. J Am Med Dir Assoc. 2018;19(1):40–Se1.
Malmstrom TK, Miller DK, Simonsick EM, Ferrucci L, Morley JE. SARC-F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes. J Cachexia Sarcopenia Muscle. 2016;7(1):28–36.
Woo J, Leung J, Morley JE. Validating the SARC-F: a suitable community screening tool for sarcopenia? J Am Med Dir Assoc. 2014; 15(9):630–4.
Woo J, Leung J, Morley JE. Defining sarcopenia in terms of incident adverse outcomes. J Am Med Dir Assoc. 2015; 16(3):247–52.
Ida S, Murata K, Nakadachi D, et al. Development of a Japanese version of the SARC-F for diabetic patients: an examination of reliability and validity. Aging Clin Exp Res. 2017;29(S):935–42.
Parra-Rodriguez L, Szlejf C, Garcia-Gonzalez AI, Malmstrom TK, Cruz-Arenas E, Rosas-Carrasco O. Cross-Cultural Adaptation and Validation of the Spanish-Language Version of the SARC-F to Assess Sarcopenia in Mexican Community-Dwelling Older Adults. J Am Med Dir Assoc. 2016; 17(12): 1142–6.
Rolland Y, Dupuy C, Abellan Van Kan G, et al. Sarcopenia Screened by the SARC-F Questionnaire and Physical Performances of Elderly Women: A Cross-Sectional Study. J Am Med Dir Assoc. 2017; 18(10):848–52.
Kotlarczyk MP, Perera S, Nace DA, Resnick NM, Greenspan SL. Identifying Sarcopenia in Female Long-Term Care Residents: A Comparison of Current Guidelines. J Am Geriatr Soc. 2018;66(2):316–20.
Locquet M, Beaudart C, Reginster JY, Petermans J, Bruyère O. Comparison of the performance of five screening methods for sarcopenia. Clin Epidemiol. 2018; 10:71–82.
Bahat G, Yilmaz O, Kilic C, Oren MM, Karan MA. Performance of SARC-F in Regard to Sarcopenia Definitions, Muscle Mass and Functional Measures. J Nutr Health Aging. 2018;22(8):898–903.
Mienche M, Setiati S, Setyohadi B, et al. Diagnostic Performance of Calf Circumference, Thigh Circumference, and SARC-F Questionnaire to Identify Sarcopenia in Elderly Compared to Asian Working Group for Sarcopenia’s Diagnostic Standard. Acta Medlndones. 2019;51(2): 117–27.
Kera T, Kawai H, Hirano H, et al. SARC-F: A validation study with community-dwelling older Japanese adults. Geriatr Gerontol Int. 2019;19(11):1172–8.
Kurita N, Wakita T, Kamitani T, Wada O, Mizuno K. SARC-F Validation and SARC-F+EBM Derivation in Musculoskeletal Disease: The SPSS-OK Study. J Nutr Health Aging. 2019;23(8):732–8.
Drey M, Ferrari U, Schraml M, et al. German Version of SARC-F: Translation, Adaption, and Validation. J Am Med Dir Assoc. 2020.
Rubenstein LZ, Harker JO, Salva A, Guigoz Y, Vellas B. Screening for undernutrition in geriatric practice: developing the short-form mini-nutritional assessment (MNASF). J Gerontol A Biol Sei Med Sei. 2001;56(6):M366–72.
Cederholm T, Bosaeus I, Barazzoni R, et al. Diagnostic criteria for malnutrition — An ESPEN Consensus Statement. Clin Nutr. 2015;34(3):335–40.
Ishida Y, Maeda K, Nonogaki T, et al. Malnutrition at Admission Predicts In-Hospital Falls in Hospitalized Older Adults. Nutrients. 2020; 12(2).
Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5(6):649–55.
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.
Santos LP, Gonzalez MC, Orlandi SP, et al. New Prediction Equations to Estimate Appendicular Skeletal Muscle Mass Using Calf Circumference: Results From NHANES 1999–2006. JPEN J Parenter Enteral Nutr. 2019;43(8):998–1007.
Wen X, Wang M, Jiang CM, Zhang YM. Anthropometric equation for estimation of appendicular skeletal muscle mass in Chinese adults. Asia Pac J Clin Nutr. 2011;20(4):551–6.
Jaeschke R, Guyatt GH, Sackett DL. Users’ guides to the medical literature. HI. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. JAMA. 1994;271(9):703–7.
McGee S. Simplifying likelihood ratios. J Gen Intern Med. 2002; 17(8):646–9.
Acknowledgments
This work was funded by the Japan Society for the Promotion of Science (grant number: JP20H01144to Ishida Y and 18K11142 to Maeda K)
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical standards: This work was performed according to the ethical standards laid down in the 1964 Declaration of Helsinki and later amendments.
Conflict of Interest: The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Ishida, Y., Maeda, K., Nonogaki, T. et al. SARC-F as a Screening Tool for Sarcopenia and Possible Sarcopenia Proposed by AWGS 2019 in Hospitalized Older Adults. J Nutr Health Aging 24, 1053–1060 (2020). https://doi.org/10.1007/s12603-020-1462-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12603-020-1462-9